UK markets closed

Evgen Pharma plc (EVG.L)

LSE - LSE Delayed price. Currency in GBp
Add to watchlist
4.90000.0000 (0.00%)
At close: 5:06PM BST
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in GBP. All numbers in thousands
Breakdown
ttm
31/03/2021
31/03/2020
31/03/2019
31/03/2018
Total revenue
194
194
0
0
-
Operating expenses
Research development
1,699
2,011
1,699
1,689
-
Selling general and administrative
565
635
565
499
-
Total operating expenses
3,398
3,398
3,146
3,120
3,026
Operating income or loss
-3,204
-3,204
-3,146
-3,120
-3,026
Interest expense
-
-
-
-
0
Income before tax
-3,213
-3,213
-3,166
-3,120
-3,026
Income tax expense
-539
-539
-451
-496
-443
Income from continuing operations
-2,674
-2,674
-2,715
-2,624
-2,583
Net income
-2,674
-2,674
-2,715
-2,624
-2,583
Net income available to common shareholders
-2,674
-2,674
-2,715
-2,624
-2,583
Basic EPS
-
-
-0.02
-0.03
-0.03
Diluted EPS
-
-
-0.02
-0.03
-0.03
Basic average shares
-
-
131,232
97,278
79,864
Diluted average shares
-
-
131,232
97,278
79,864
EBITDA
-
-3,186
-3,125
-3,099
-3,005